| Veröffentlichte Version Download ( PDF | 7MB) | Lizenz: Creative Commons Namensnennung 4.0 International |
Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics
Artikel
Vallaster, Bernadette, Forster, Lisa
, Bresinsky, Merlin Niklas
, Wirth, Lukas, Fuller, Jessica L.
, Shibatani, K., Lapcinski, Ian P., Liu, Peng, Mudaliar, Deepti, Hubmann, Alexander, Daschner, Jonas, Pongratz, Herwig, Ködel, Marlisa, Yang, M., Ashe, Karen H., Walters, Michael A.
und Pockes, Steffen
(2026)
Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics.
Journal of Medicinal Chemistry.
DOI zum Zitieren dieses Dokuments: 10.5283/epub.83190
Zusammenfassung
Caspase-2 (Casp2) has emerged as a promising target for tau-associated neurodegenerative diseases, yet the development of potent, selective, and drug-like inhibitors remains challenging. Here, we report a systematic structure–activity relationship study of 80 novel covalent-reversible peptidomimetic Casp2 inhibitors, revealing key structural features of the Casp2 S2–S3 binding site and ...
Caspase-2 (Casp2) has emerged as a promising target for tau-associated neurodegenerative diseases, yet the development of potent, selective, and drug-like inhibitors remains challenging. Here, we report a systematic structure–activity relationship study of 80 novel covalent-reversible peptidomimetic Casp2 inhibitors, revealing key structural features of the Casp2 S2–S3 binding site and discovering (S)-2-methylindoline-2-carboxylic acid (2-Me-Idc) and quinaldic acid (Quin) as versatile and stable P5 scaffolds. One-step conversion of the aldehyde warhead into a nitrile remarkably enhanced selectivity while maintaning potency. The results culminate in MUR-2425 (87, (2-Me-Idc)(hE)VP*D-CN), a nanomolar Casp2 inhibitor (pKi (cpCasp2) = 7.75) with ≥525-fold selectivity over Casp1/3/4/5/6/7/9/10 and 24-fold over Casp8. MUR-2425 prevents the formation of neurotoxic Δtau314 in vitro, exhibits stable ADMET properties across human, rat, and mouse species and proves brain penetrance after subcutaneous injection in CD-1 mice. MUR-2425 is confirmed to engage Casp2 covalently by cocrystallization, supporting its further development for Alzheimer’s disease and related dementias.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | Journal of Medicinal Chemistry | ||||
| Verlag | ACS | ||||
| Open Access Art | ACS Hybrid | ||||
| Datum | 5 November 2026 | ||||
| Veröffentlichungsdatum | 17 Nov 2026 09:21 | ||||
| Institutionen | Chemie und Pharmazie > Institut für Pharmazie Chemie und Pharmazie > Institut für Pharmazie > Lehrstuhl Pharmazeutische / Medizinische Chemie I (Prof. Elz) | ||||
| Projekte |
Gefördert von:
Deutsche Forschungsgemeinschaft (DFG)
(527849699)
| ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | Inhibitors; Peptides and proteins; Aldehydes; Rodent models; Central nervous system | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 615 Pharmazie | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-831900 | ||||
| Dokumenten-ID | 83190 |
Downloadstatistik
Downloadstatistik